These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24710150)

  • 1. Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects.
    Pouw MH; Kwon BK; Verbeek MM; Vos PE; van Kampen A; Fisher CG; Street J; Paquette SJ; Dvorak MF; Boyd MC; Hosman AJ; van de Meent H
    Spinal Cord; 2014 Jun; 52(6):428-33. PubMed ID: 24710150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury.
    Kwon BK; Stammers AM; Belanger LM; Bernardo A; Chan D; Bishop CM; Slobogean GP; Zhang H; Umedaly H; Giffin M; Street J; Boyd MC; Paquette SJ; Fisher CG; Dvorak MF
    J Neurotrauma; 2010 Apr; 27(4):669-82. PubMed ID: 20038240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of neuron-specific enolase and S-100beta protein level in experimental acute spinal cord injury.
    Cao F; Yang XF; Liu WG; Hu WW; Li G; Zheng XJ; Shen F; Zhao XQ; Lv ST
    J Clin Neurosci; 2008 May; 15(5):541-4. PubMed ID: 18343116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal Fluid Biomarkers To Stratify Injury Severity and Predict Outcome in Human Traumatic Spinal Cord Injury.
    Kwon BK; Streijger F; Fallah N; Noonan VK; Bélanger LM; Ritchie L; Paquette SJ; Ailon T; Boyd MC; Street J; Fisher CG; Dvorak MF
    J Neurotrauma; 2017 Feb; 34(3):567-580. PubMed ID: 27349274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Injury Severity and Neurological Recovery after Acute Cervical Spinal Cord Injury: A Comparison of Cerebrospinal Fluid and Magnetic Resonance Imaging Biomarkers.
    Dalkilic T; Fallah N; Noonan VK; Salimi Elizei S; Dong K; Belanger L; Ritchie L; Tsang A; Bourassa-Moreau E; Heran MKS; Paquette SJ; Ailon T; Dea N; Street J; Fisher CG; Dvorak MF; Kwon BK
    J Neurotrauma; 2018 Feb; 35(3):435-445. PubMed ID: 29037121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury.
    Ahadi R; Khodagholi F; Daneshi A; Vafaei A; Mafi AA; Jorjani M
    Spine (Phila Pa 1976); 2015 Jul; 40(14):E823-30. PubMed ID: 25341992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid concentrations of nitric oxide metabolites in spinal cord injury.
    Kimura S; Hosaka N; Yuge I; Yamazaki A; Suda K; Taneichi H; Denda H; Endo N
    Spine (Phila Pa 1976); 2009 Aug; 34(18):E645-52. PubMed ID: 19680090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica.
    Brisby H; Olmarker K; Rosengren L; Cederlund CG; Rydevik B
    Spine (Phila Pa 1976); 1999 Apr; 24(8):742-6. PubMed ID: 10222523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury.
    Pleines UE; Morganti-Kossmann MC; Rancan M; Joller H; Trentz O; Kossmann T
    J Neurotrauma; 2001 May; 18(5):491-8. PubMed ID: 11393252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CSF and Serum Neurofilament Light and Glial Fibrillary Acidic Protein, Injury Severity, and Outcome in Spinal Cord Injury.
    Stukas S; Cooper J; Gill J; Fallah N; Skinnider MA; Belanger L; Ritchie L; Tsang A; Dong K; Streijger F; Street J; Paquette S; Ailon T; Dea N; Charest-Morin R; Fisher CG; Bailey CS; Dhall S; Mac-Thiong JM; Wilson JR; Christie S; Dvorak MF; Wellington CL; Kwon BK
    Neurology; 2023 Mar; 100(12):e1221-e1233. PubMed ID: 36599698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Cerebrospinal Fluid Ubiquitin C-Terminal Hydrolase L1 as a Biomarker of Human Acute Traumatic Spinal Cord Injury.
    Stukas S; Gill J; Cooper J; Belanger L; Ritchie L; Tsang A; Dong K; Streijger F; Street J; Paquette S; Ailon T; Dea N; Charest-Morin R; Fisher CG; Dhall S; Mac-Thiong JM; Wilson JR; Bailey C; Christie S; Dvorak MF; Wellington C; Kwon BK
    J Neurotrauma; 2021 Aug; 38(15):2055-2064. PubMed ID: 33504255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study.
    Hayakawa K; Okazaki R; Ishii K; Ueno T; Izawa N; Tanaka Y; Toyooka S; Matsuoka N; Morioka K; Ohori Y; Nakamura K; Akai M; Tobimatsu Y; Hamabe Y; Ogata T
    Spinal Cord; 2012 Jul; 50(7):493-6. PubMed ID: 22270191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant correlation between cerebrospinal fluid nitric oxide concentrations and neurologic prognosis in incomplete cervical cord injury.
    Hosaka N; Kimura S; Yamazaki A; Wang X; Denda H; Ito T; Hirano T; Endo N
    Eur Spine J; 2008 Feb; 17(2):281-6. PubMed ID: 17712576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Targeted Proteomics Analysis of Cerebrospinal Fluid after Acute Human Spinal Cord Injury.
    Streijger F; Skinnider MA; Rogalski JC; Balshaw R; Shannon CP; Prudova A; Belanger L; Ritchie L; Tsang A; Christie S; Parent S; Mac-Thiong JM; Bailey C; Urquhart J; Ailon T; Paquette S; Boyd M; Street J; Fisher CG; Dvorak MF; Borchers CH; Foster LJ; Kwon BK
    J Neurotrauma; 2017 Jun; 34(12):2054-2068. PubMed ID: 28276985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic criteria of traumatic central cord syndrome. Part 3: descriptive analyses of neurological and functional outcomes in a prospective cohort of traumatic motor incomplete tetraplegics.
    Pouw MH; van Middendorp JJ; van Kampen A; Curt A; van de Meent H; Hosman AJ
    Spinal Cord; 2011 May; 49(5):614-22. PubMed ID: 21151190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: a prospective pilot study.
    Wichmann TO; Kasch H; Dyrskog S; Høy K; Møller BK; Krog J; Hoffmann HJ; Hviid CVB; Rasmussen MM
    Acta Neurochir (Wien); 2023 Jun; 165(6):1417-1425. PubMed ID: 36790588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum biomarkers for experimental acute spinal cord injury: rapid elevation of neuron-specific enolase and S-100beta.
    Loy DN; Sroufe AE; Pelt JL; Burke DA; Cao QL; Talbott JF; Whittemore SR
    Neurosurgery; 2005 Feb; 56(2):391-7; discussion 391-7. PubMed ID: 15670387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of intramedullary lesion expansion rate on MR images of patients with subaxial spinal cord injury.
    Le E; Aarabi B; Hersh DS; Shanmuganathan K; Diaz C; Massetti J; Akhtar-Danesh N
    J Neurosurg Spine; 2015 Jun; 22(6):611-21. PubMed ID: 25746115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.
    Schmidt FM; Mergl R; Stach B; Jahn I; Schönknecht P
    World J Biol Psychiatry; 2015 Feb; 16(2):106-13. PubMed ID: 25264292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year.
    Inada T; Takahashi H; Yamazaki M; Okawa A; Sakuma T; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Mannoji C; Miyashita T; Kadota R; Someya Y; Ikeda O; Hashimoto M; Suda K; Kajino T; Ueda H; Ito Y; Ueta T; Hanaoka H; Takahashi K; Koda M
    Spine (Phila Pa 1976); 2014 Feb; 39(3):213-9. PubMed ID: 24299727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.